急性髓系白血病（AML）和高危骨髓增生异常综合征（MDS）治疗面临诸多挑战，免疫疗法效果不佳。研究人员针对 RNA 剪接因子突变开展研究，识别出一系列错剪衍生新抗原及相关 TCR。这为白血病免疫治疗提供新思路，有望改善患者预后。

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

*仅供医学专业人士阅读参考大家有没有这样的经历：某些生活里原本无处不在、司空见惯的东西，有朝一日突然才发现，它们其实特别重要呢？在奇点糕最常聊到的肿瘤微环境里，还真有个角色符合这些条件。当然，这里说的既不是癌细胞也不是免疫细胞，奇点糕甚至之前几乎没谈 ...

Primary Immunodeficiency (PID) in India poses a significant health concern, with under-recognition hindering diagnosis and treatment accessibility.

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Objective The nature of the tumour-infiltrating leucocytes (TILs) is known to impact clinical outcome in carcinomas, including hepatocellular carcinoma (HCC). However, the role of tumour-infiltrating ...

他们发现，QRICH1是CARD11信号传导的调节因子。QRICH1在TCR接合后以自调节的方式与CARD11结合，并负向调节CARD11信号传导，从而上调NF-κB。CARD11与QRICH1之间的这种相互作用可调节CD8+ T细胞的活化和功能。 Pomerantz表示，研究人员下一步打算研究缺乏QRICH1蛋白的T细胞 ...

Hosted by BioBuzz, BitsInBio, Atria, and Zetta, AI x Bio Philly brought together innovators, entrepreneurs, and investors for an evening of demos, discussion, and insight into how AI is shaping the ...